A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism. [electronic resource]
- Journal of neurochemistry Oct 2002
- 186-92 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0022-3042
10.1046/j.1471-4159.2002.01144.x doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Animals DNA--metabolism Disease Models, Animal Electrophoretic Mobility Shift Assay Immunoblotting Male Mesencephalon--chemistry Mice Mice, Inbred C57BL Neurons--drug effects Parkinsonian Disorders--chemically induced Poly Adenosine Diphosphate Ribose--metabolism Poly(ADP-ribose) Polymerases--metabolism Precipitin Tests Protein Binding--physiology Protein Processing, Post-Translational Tumor Suppressor Protein p53--metabolism